735: Flavonoids mitigate pain by interacting with TRPV1: Novel in -silico and in-vivo evidences
Topic: Basic Science
Subtopic: Pain category (ICD-11), Other acute pain category, , , , , , , , , , Pharmacological interventions, Drug development, Behavioral studies
Background and Aims: Transient receptor potential vanilloid 1 (TRPV1) is a key ion channel expressed in nociceptive sensory neurons that mediates pain signaling(1). It is activated by stimuli such as capsaicin, heat, and protons, leading to calcium influx, increased neuronal excitability, and release of pro-inflammatory cytokines and neuropeptides like CGRP and Substance P (2). Although TRPV1 is an important therapeutic target, current modulators (agonists, antagonists, and RNA interference) have limitations including pungency, desensitization, and thermoregulatory side effects (3). Capsazepine, a widely used antagonist, can induce hypothermia and requires high in vivo doses (3). This study aimed to identify safer and cost-effective agents with antinociceptive potential and to elucidate their mechanisms in inhibiting capsaicin-induced TRPV1 activation and its downstream signaling pathways.
Methods: The structure of Capsaicin (2N27) was extracted from 3J5R and the structure of Naringenin, Naringin, and Kaempferol was downloaded from PubChem. The TRPV1 structure was downloaded from RCSB Protein Data Bank (3J5R). The TRPV1 structure was reconstructed by using Modeller. Energy minimization of reconstructed TRPV1 was done using Swiss PDB viewer. Protein-ligand docking was performed using Auto Dock 4.2. Based on docking outcomes, Kaempferol, Naringin, and Naringenin were selected for in-vivo validation. Acute inflammatory pain was induced by intraplantar injection of capsaicin (200 µg/kg) in mice left hind paw (4). Thermal hyperalgesia and mechanical allodynia were assessed using hot plate (5) and von Frey tests (6), respectively. Locomotor activity and anxiety-like behaviors were evaluated before and after 24 h of treatment using open field (7) and elevated plus maze (8) tests. Molecular analyses were conducted using Western blotting, ELISA, and antioxidant assays (9).
Results: Kaempferol (−4.3 kcal/mol) and Naringenin (−5.44 kcal/mol) showed comparatively higher binding affinity near the TRPV1 pore region, whereas Naringin (−2.07 kcal/mol) bind to the capsaicin binding site to TRPV1. Kaempferol, Naringin and Naringenin reduced Capsaicin induced nociceptive responses like paw edema and paw licking. They inhibited thermal hyperalgesia, mechanical allodynia, anxiety-like behaviors(3-3.5 fold) and motor activity(1.25-1.5 fold) induced by Capsaicin. At the cellular level, those three flavonoids decreased expression of TRPV1(1.5-3.3 fold), Calmodulin (8.2-11.4 fold) and CaMKII (2.1-3.2 fold) in the spinal cord. They reduced the level of Substance P (1.2-1.8 fold), CGRP (1.2-2.1) and intracellular reactive oxygen species generation in the paw and spinal cord. Treatment with Kaempferol, Naringin and Naringenin restored SOD (1.5-2.1fold), Catalase (2.3-3.2 fold) and GSH (1.5-3 fold) levels.
Conclusions: The typical flavonoid structures have favored the suitable bindings in TRPV1 channel in rescuing the capsaicin induced cellular events of pain. The comparative analysis using in silico and in vivo systems proved that the Naringenin showed best efficacy among three compounds mitigating acute inflammatory pain conditions. This is a novel evidence based contribution in pain management.
References: 1.Xiao T, Sun M, Kang J, Zhao C. Transient Receptor Potential Vanilloid1 (TRPV1) Channel Opens Sesame of T Cell Responses and T Cell-Mediated Inflammatory Diseases. Front Immunol. 2022 May 11;13:870952. doi: 10.3389/fimmu.2022.870952. PMID: 35634308; PMCID: PMC9130463.
2. Shuba YM. Beyond Neuronal Heat Sensing: Diversity of TRPV1 Heat-Capsaicin Receptor-Channel Functions. Front Cell Neurosci. 2021 Feb 5;14:612480. doi: 10.3389/fncel.2020.612480. PMID: 33613196; PMCID: PMC7892457. +
3. Rahman MM, Jo YY, Kim YH, Park CK. Current insights and therapeutic strategies for targeting TRPV1 in neuropathic pain management. Life Sci. 2024 Oct 15;355:122954. doi: 10.1016/j.lfs.2024.122954. Epub 2024 Aug 10. PMID: 39128820.
4. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature. 1997 Oct 23;389(6653):816-24. doi: 10.1038/39807. PMID: 9349813.
5. Menéndez L, Lastra A, Hidalgo A, Baamonde A. Unilateral hot plate test: a simple and sensitive method for detecting central and peripheral hyperalgesia in mice. J Neurosci Methods. 2002 Jan 15;113(1):91-7. doi: 10.1016/s0165-0270(01)00483-6. PMID: 11741726.
6. Bonin RP, Bories C, De Koninck Y. A simplified up-down method (SUDO) for measuring mechanical nociception in rodents using von Frey filaments. Mol Pain. 2014 Apr 16;10:26. doi: 10.16/1744-8069-10-26. PMID: 24739328; PMCID: PMC4020614.
7. Mo18narca RI, Silva RFB, Gabriel SI, Cerveira AM, von Merten S. The Presence of a Shelter in an Open Field Test Has Differential Effects on the Behavior and Stress Response of Two Mouse Species. J Exp Zool A Ecol Integr Physiol. 2025 May;343(4):480-492. doi: 10.1002/jez.2904. Epub 2025 Jan 27. PMID: 39868581; PMCID: PMC11959681.
8. Komada M, Takao K, Miyakawa T. Elevated plus maze for mice. J Vis Exp. 2008 Dec 22;(22):1088. doi: 10.3791/1088. PMID: 19229173; PMCID: PMC2762911.
9. Bhattacharya T, Gupta A, Gupta S, Saha S, Ghosh S, Shireen Z, Dey S, Sinha S. Benzofuran Iboga-Analogs Modulate Nociception and Inflammation in an Acute Mouse Pain Model. Chembiochem. 2024 Aug 19;25(16):e202400162. doi: 10.1002/cbic.202400162. Epub 2024 Jul 29. PMID: 38874536.
Presenting Author: Rimi Das
Submitting Author: Rimi Das
Senior Author: Prof. Sanjit Dey
IASP 2026 Global Year theme of Neuropathic Pain: Yes
Co-Authors:
- Tuhin Bhattacharya: Ph.D - University of Gothenburg
- Sabnur Parvage: M.Sc - University of Calcutta
- Chaitali Mukhopadhyay: Ph.D - University of Calcutta
- Prof. Sanjit Dey: Ph.D - University of Calcutta
Flavonoids mitigate pain by interacting with TRPV1: Novel in -silico and in-vivo evidences
Category
Poster
Description
Session Type: Posters
Room: Exhibit Hall EH102-103
28/10/2026
03:15 PM - 04:45 PM